林晓阳 - 北京航空航天大学 - 集成电路科学与工程学院

个人简介

2010年及2015年先后于清华大学获理学学士及博士学位（导师：姜开利教授）。2014年于法国南巴黎大学访问（合作导师：赵巍胜教授及诺奖得主Albert Fert教授）。2015年8月入职北京航空航天大学。目前担任集成电路材料与器件系系主任。研究方向为自旋电子材料、器件及设备，主要成果包括：实验实现了金属—绝缘体转变调控磁性多层膜的层间交换耦合效应；实验发现了二维材料WSe2自旋阀器件随层数和堆垛类型而发生正负振荡的新奇磁阻现象，揭示了基于谷-塞曼有效场的进动型自旋翻转新机制，提出多个低功耗二维自旋电子器件方案；基于全光翻转技术及材料体系设计，实验实现了写入速度达到10皮秒量级的新型磁存储器件，在写入速度方面，超越现有器件技术1-2个数量级；将机器学习算法与光学显微分析技术相结合，研制了全球首套二维材料智能光学识别原型系统。已发表SCI论文50余篇，包括第一作者或通讯作者Nature Electronics、PNAS、Nature Communications、Applied Physics Reviews、Matter、Nano Letters、ACS Nano、Nano Research(纳米研究)、Physical Review Applied、Advanced Electronic Materials、Advanced Quantum Technologies、IEEE Electron Device Letters等SCI期刊论文30余篇，多篇论文入选ESI热点论文、高被引论文、期刊封面、当期优秀论文及Featured Articles，获得AIP Scilight、StorageNewsletter、MRAM-info、Mat+等媒体报道；拥有30余项中国发明专利、20余项美国发明专利，5项获得转化。先后主持国家重点研发计划战略高技术项目、国家自然科学基金等项目，参与973项目、国家自然科学基金重大科研仪器研制项目等多个科研项目。担任Nature Communications、Nano Letters、APL、ACS Applied Nano Materials、IEEE Trans. Nanotechnol等期刊的审稿人。担任Advanced Devices & Instrumentation期刊编委（Associate Editor）、Scientific Reports期刊编委（Editorial Board Member）、中国电子学会会员及IEEE Senior Member。先后获得吴有训奖（清华大学物理系）、清华大学优秀学位论文（学士、博士）、北航“我爱我师”优秀青年教师、北航青年拔尖人才支持计划、北航优秀教学成果奖一等奖、北京市高等教育教学成果奖二等奖等奖项。入选中国科协第四届“青年人才托举工程”（2018）。入选教育部青年长江学者（2022）。

研究领域

新型低功耗自旋电子器件新型信息材料与器件特色集成电路装备

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease Transcranial Electromagnetic Treatment Stops Alzheimer’s Disease Cognitive Decline over a 2?-Year Period: A Pilot Study The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models Arginase 1 Insufficiency Precipitates Amyloid-β Deposition and Hastens Behavioral Impairment in a Mouse Model of Amyloidosis An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β An Open-Label, Prospective Study Evaluating the Clinical and Immunological Effects of Higher Dose Granulocyte Colony-Stimulating Factor in ALS A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer’s Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging THE RATIONALE OF MUTATED AMYLOID BETA SENSITIZED DENDRITIC CELLS AS A THERAPEUTIC VACCINE FOR ALZHEIMER’S DISEASE Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease AN IMMUNOMODULATORY VACCINE AGAINST Aβ FOR ALZHEIMER’S DISEASE Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients Small Antimicrobial Agents Based on Acylated Reduced Amide Scaffold Polymer-Encapsulated Aβ Peptide Fragments as an Oligomeric-Specific Vaccine for Alzheimer's Disease Brain-derived Neurotrophic Factor Signaling Pathway: Modulation by Acupuncture in Telomerase Knockout Mice Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapy Helical Antimicrobial Sulfono-γ-AApeptides Evaluation of an α synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson disease Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease The Potential Therapeutic Effects of THC on Alzheimer's Disease Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain Anti-aggregation effect of AA-peptide on beta-amyloid peptides in Alzheimer's disease Hippocampal Neurogenesis and the Brain Repair Response to Brief Stereotaxic Insertion of a Microneedle Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer’s Disease in APP+PS1 Mice Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells The role of CD8 T cell and its receptor change in Alzheimer's disease Pilot Study of Granulocyte-Colony Stimulating Factor for Treatment of Alzheimer's Disease Efficacy of a Therapeutic Vaccine Using Mutated β-amyloid Sensitized Dendritic Cells in Alzheimer’s Mice High Blood Caffeine Levels in MCI Linked to Lack of Progression to Dementia Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: A mechanism for electromagnetic field-induced cognitive benefit? Green Tea Epigallocatechin-3-Gallate (EGCG) and Other Flavonoids Reduce Alzheimer's Amyloid-Induced Mitochondrial Dysfunction Caffeine Synergizes with Another Coffee Component to Increase Plasma GCSF: Linkage to Cognitive Benefits in Alzheimer's Mice IOS Press Electromagnetic Field Treatment Protects Against and Reverses Cognitive Impairment in Alzheimer’s Disease Mice Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-beta Levels in Aged Alzheimer's Disease Mice Caffeine Suppresses Amyloid-beta Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice Cognitive and pathological benefits of Aβ-sensitive Th2 cells are independent of Antigen-Specific B cell activation Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer’s mice Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice Aβ-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS Mutant Amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine O3-05-06: Nanoparticle Alzheimer's disease vaccine targeting oligomeric Abeta P1-068: Environmental enrichment “sessions” are sufficient to provide cognitive benefit to impaired Alzheimer's transgenic mice without affecting brain or plasma Aβ levels P2-309: Granulocyte-colony simulating factor reduces hippocampal amyloid load and improves behavioral performance in a transgenic Alzheimer's disease mouse model ICP3-174: Plasma Aβ level can be used as marker for AD treatment in PS1/APP Alzheimer's mouse model O1-04-04: Caffeine reverses cognitive impairment, decreases β-amyloid levels, and reduces inflammation in aged Alzheimer's mice: Implications for Alzheimer's treatment O3-05-08: Amyloid-β-responsive Th2 cells reduce microglial activation, reduce serum cytokines, increase plasma amyloid-β, and improve hippocampal-dependent memory in APP+PS1 mice Age related changes in clonalities of T cell Age –related changes in clonalities of T cell receptor Vβ repertoire within CD8 subsets, but not CD4 in healthy individuals Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid β peptides